Brevan Howard Capital Management LP Twist Bioscience Corp Transaction History

Brevan Howard Capital Management LP

  • $14.2 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$27.95 - $53.0 $274,916 - $521,308
9,836 New
9,836 $484,000
Q4 2021

Feb 14, 2022
SELL
$75.47 - $135.88 $1.54 Million - $2.78 Million
-20,439 Closed
0 $0
Q3 2021

Nov 12, 2021
SELL
$95.64 - $131.48 $217,294 - $298,722
-2,272 Reduced 10.0%
20,439 $2.19 Million
Q1 2021

May 14, 2021
SELL
$105.48 - $207.97 $9.42 Million - $18.6 Million
-89,289 Reduced 79.72%
22,711 $2.81 Million
Q4 2020

Feb 12, 2021
BUY
$76.64 - $167.89 $8.58 Million - $18.8 Million
112,000 New
112,000 $15.8 Million

Others Institutions Holding TWST

# of Institutions
256
Shares Held
66.6M
Call Options Held
127K
Put Options Held
45.4K
View Full List

About Twist Bioscience Corp

TWST Quotes by TradingView
  • Ticker TWST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 56,363,500
  • Market Cap $2.68B
  • Description
  • Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...
More about TWST
Track This Portfolio

Track Brevan Howard Capital Management LP Portfolio

Follow Brevan Howard Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brevan Howard Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Brevan Howard Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email